Wacker Chemie AG (Wacker Chemie AG I) aksje

Wacker Chemie AG, together with its subsidiaries, produces and sells chemical products in Europe, Asia, the Americas, and internationally. The company operates through four segments: Silicones, Polymers, Biosolutions, and Polysilicon. It offers silanes, siloxanes, silicone fluids, silicone emulsions, silicone elastomers, silicone resins, and pyrogenic silica; and binders and polymeric additives, including dispersible polymer powders and dispersions. The company also provides pharmaceutical proteins, vaccines, cyclodextrins, cysteine, polyvinyl acetate solid resins, and acetylacetone, as well as pharmaceutical actives, food additives, and agrochemicals; and hyperpure polysilicon. In addition, it engages in forums; e-business, such as ERP system, EDI integration, delivery forecast, and e-invoicing; and support services. The company serves automotive, construction, chemical, semiconductor, consumer goods, medical technology, pharmaceutical, and photovoltaic industries. It exports its products. The company was formerly known as Wacker-Chemie GMBH and changed its name to Wacker Chemie AG in October 2005. Wacker Chemie AG was founded in 1914 and is headquartered in Munich, Germany. The company operates as a subsidiary of Dr. Alexander Wacker Familiengesellschaft mbH.